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Conclusion: Audiological tests in patients with bacterial
meningitis, especially children, should be started as soon as
possible after the acute phase is over. As we found no
deterioration of initial normal hearing after bacterial menin-
gitis, repeated audiometry seems indicated only for those
with diagnosed hearing loss at first assessment. Key
Words: Audiology—Bacterial meningitis—Follow-up—
Hearing loss.
Otol Neurotol 39:e301–e306, 2018.ommon sequelae of bacterial men- the Cochlear Implant Group protocOne of the most c
ingitis with high impact on general functioning is hearing
loss, either unilateral or bilateral, and varying from mild
to profound. Timely administration of dexamethasone or
other steroids, preferably before hearing loss, is diag-
nosed, generally reduces the risk of hearing loss (1).
As cochlear inflammation can progress into ossifica-
tion of the cochlear lumen, early diagnosis will enable
placement of a cochlear implant before ossification takes
place and electrode insertion becomes impossible.
There is international consensus on the need for
early audiological testing (2–5), but not about the
extent of audiological follow-up. In the Netherlands,ol prescribes audio-
logical assessment as soon as the patient’s condition
permits this, and advises audiological follow-up at 1,
2, 6, and 12 months when the first test showed normal
hearing (5).
A recent systematic review could include only a few
studies addressing the course of hearing loss after bacte-
rial meningitis (6). From the results of these studies it was
concluded that late onset hearing loss is very rare (7–12).
A general downside to all studies included is the basic,
sometimes nonquantitative, description of the audiomet-
ric results. Also, the exact time of onset of hearing loss
remained unclear in most studies.
Therefore, additional research is needed. In this study,
we analyzed data from the medical records of patients
with bacterial meningitis in our own hospital to first
clarify the incidence, course and onset of hearing loss
after bacterial meningitis. Secondly, we established com-
pliance to audiometric testing protocol.
The results of this study can help improve current
recommendations for audiological follow-up.
METHODS
Study Design
Data collected in the Erasmus University Medical Center
(Erasmus MC, Rotterdam, The Netherlands) was used for this
retrospective cohort study. This hospital accounts for 25% of function and the results of tympanometry. Only sensorineural
e302 M. B. A. RODENBURG-VLOT ET AL.pediatric intensive care hospitalizations and 3.5% of adult IC
hospitalizations in the Netherlands. Its audiological department
has a regional function for audiological tests of babies and
young children.
Patient Inclusion
Patients with bacterial meningitis were identified via the
Erasmus MC financial registration system, the diagnosis
codes in the electronic medical records, and the Dutch Reference
Laboratory forBacterialMeningitis database (NRLBM: ‘‘Neder-
lands Referentielaboratorium voor Bacterie¨le Meningitis’’).
The NRLBM receives cerebrospinal fluid and blood samples
of about 90% of all patients with bacterial meningitis in the
Netherlands (13) and provided us with a list of patients with
bacterial meningitis treated in Erasmus MC between 1985 and
2015. All these patients were considered to be confirmed cases.
The medical records of the patients identified through the finan-
cial registration system or diagnosis code were screened for
information on lumbar puncture, symptoms, and treatment.
Patients were excluded if they had not been treated for bacterial
meningitis or if lumbar puncture had shown negative culture
results and low number of leukocytes. Another exclusion crite-
rion was pre-existing hearing loss or recurrent meningitis with an
unclear relation between the episodes of meningitis and
hearing loss.
We distinguished three cohorts, data of each of which served
to answer specific questions (Fig. 1).
Cohort 1: Patients treated for bacterial meningitis in our
hospital; their data was used to answer the questions on patho-
gen distribution and adherence to the audiometry follow-
up protocol.
Cohort 2: A subgroup of patients identified through the
Erasmus MC audiometry database. These patients had been
diagnosed with bacterial meningitis in another hospital and
referred to our hospital for audiological assessment. Those with
adequate audiometry and those with adequate audiometry from
Cohort 1 together formed Cohort 2. Their data was used to
answer the questions on the incidence of hearing loss and
pathogen distribution.
Cohort 3: A subgroup of patients from Cohort 2 for
whom repeated audiometry was available; their data was used
to study the course and timing of hearing loss after meningitis
(Fig. 1).
Data Extraction
From each medical record the following information was
retrieved: date of birth, date of meningitis, type of pathogen, and
audiometric data. Audiometric data was discarded if more than
1 year had elapsed between the treatment of meningitis and the
audiometric testing, or if the last assessment had been per-
formed less than 3 months or more than 2 years after the
first assessment.
Sensorineural hearing loss was classified according to the
World Health Organisation grades of hearing impairment (14).
Hearing loss was defined as a sensorineural loss of 25 dB, based
on the high-frequency pure-tone average or auditory brainstem
response (ABR) threshold. The high-frequency pure-tone aver-
age is the average hearing threshold at 1, 2, and 4 kHz in dBHL,
and it was calculated using the bone conduction thresholds. In
case of ABR data (click-stimulation), the response threshold
corresponds to the hearing threshold around 3 kHz plus 10 dB.
Conductive hearing losses were estimated by one of the
researchers (L.R.) from the shape of the latency-intensityOtology & Neurotology, Vol. 39, No. 5, 2018hearing losses were included in the analysis. Hearing loss was
considered stable when the difference between the results of
two consecutive assessments was less than 15 dB.
Results
Patient Selection and Audiometric Data
Cohort 1 consisted of 655 patients. As to age distribu-
tion, 246 were< 4 years old, 107 from 4 to 17 years old,
and 30218 years old. Lumbar puncture was positive for
bacterial meningitis in 584 patients; in the other 71,
treatment for bacterial meningitis was started based on
clinical presentation (n¼ 31), number of leukocytes in
the cerebrospinal fluid (n¼ 24), or a diagnosis made in a
referring hospital (n¼ 16), see Figure 1.
Most patients of meningitis in Cohort 1 were caused by
S. pneumoniae (164 patients, 25%), followed by N.
meningitides (163 patients, 25%), and Haemophilus
influenzae type B (56 patients, 9%). In total 183 patients
(28%) were caused by other (less frequently occurring)
pathogens and in 89 patients (14%) no pathogen was
identified but cerebrospinal fluid showed pleiocytosis.
Audiometric data were available for 174 of the 655
patients (27%) in Cohort 1. The younger the age, the
higher the availability: 56% of the babies had audiometry
data available against 14% of the adults. The most
frequent reasons for missing audiometric data were: rapid
death or bad condition (19%, 89/481) and transfer to
another hospital (13%, 63/481), with various other rea-
sons in 8% (22/481). In 64% (307/481) reasons for
missing audiometry were not clear from the medical
record, but seemed related to age in particular: in 34%
of the babies without audiometry the reason for the
lack of audiometry was unknown against 71% of the
adults.
Cohort 2 consisted of 252 patients, that is 174 from
Cohort 1 and 78 identified from the ABR database of the
audiological department with both a history of meningitis
and available audiometric data (74 (<4 yr old and 4 from
4 to18 yr old). Audiometry had been performed at a
median interval of 43 (interquartile range [IQR] 19–105)
days after meningitis.
Cohort 3 consisted of 110 patients whose hearing had
been tested twice or more (Cohort 3, Fig. 1). The median
interval between first and last test was 217 (IQR 168–
355) days.
Incidence of Hearing Loss and Determinants
Hearing loss had been diagnosed in 69 of the 252
patients in Cohort 2 (27%, 95% CI 22–33%). The mean
incidence of profound hearing loss (in at least one ear)
was 13% (33/252 patients, 95% CI 10–18%), which was
bilateral in almost half of these patients (6% of all
patients, 16/252, 95% CI 4–10%).
Hearing loss was significantly age-related with an
incidence of 63% (15/24, 95% CI 43–79%) in the over
17-year-olds and 24% (54/228, CI 19–30%) in children.
In the latter group it was significantly more often
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FIG. 1. Patient inclusion scheme.
REPEATED AUDIOMETRY AFTER BACTERIAL MENINGITIS e303profound than in the adult population (56% against 20%,
odd’s ratio 5, 95% CI 1, 3–20) (Table 1).
The distribution of pathogens in Cohort 2 was
not significantly different from that of Cohort 1. In thesubgroup of Cohort 2, patients diagnosed with hearing
loss suffered significantly more frequently from pneumo-
coccal meningitis than those without hearing loss
(Table 2).Otology & Neurotology, Vol. 39, No. 5, 2018
TABLE 1. Grades of hearing loss per age category
Hearing at First Test Young Children (0-3 yr) Children (4–17 yr) Adults (>18yr)
Normal hearing 153 (77%) 21 (75%) 9 (38%)
Slight hearing loss 14 (7%) 0 (0%) 4 (17%)
Moderate hearing loss 6 (3%) 1 (4%) 2 (8%)
Severe hearing loss 3 (2%) 0 (0%) 6 (25%)
Profound hearing loss 24 (12%) 6 (21%) 3 (13%)
total 200 (100%) 28 (100%) 24 (100%)
total hearing loss 47 (24%) 7 (25%) 15 (63%)
e304 M. B. A. RODENBURG-VLOT ET AL.Course of Hearing Loss
Of 110 patients with repeated audiometry in Cohort 3,
82 (75%, 95% CI 66–82%) had normal hearing at the
first assessment. Follow-up audiometry in these 82
patients did not reveal deterioration of hearing, although
in 6 patients only data for one ear was available. In 19 of
the 28 patients with diagnosed hearing loss after menin-
gitis (20 unilateral, 8 bilateral) audiometry results
remained stable, although in one patient only data for
one ear was available (Fig. 2). Nine patients showed
changes in hearing over time (Fig. 2). For six of them the
hearing improved: in four patients even from mild hear-
ing loss to normal hearing. One had a unilateral profound
hearing loss after an infection with an unknown pathogen
around birth, which showed fluctuations to a severe
unilateral hearing loss. Two had a unilateral hearing loss
(one moderate, one profound) with deterioration of the
normal hearing ear to a moderate hearing loss in both,
progressing to bilateral hearing loss.
Both patients who developed a hearing loss in the other
ear had neonatal meningitis; in one patient due to an
infection of a group B streptococcus and in the other
due to E. coli infection. The patient with a group B
streptococcus infection initially had a normal response
on the ABR in one ear, including a normal I-V interval
although both I and V-latency were lengthened, and
otoacoustic emissions were present. However, after 70
days, the otoacoustic emissions had disappeared while the
tympanogram was normal. The ABR result 15 days later
showed a hearing loss of 60 dB HL and a delayed I-V
interval. The patient with an infection due to E. coli had
delayed latencies at the first ABR, which took placeTABLE 2. Cohort description: pathogen distributi
Cohort 1 655
Pathogen distribution
S. pneumoniae 164 25% (CI 22–2
N. meningitides 163 25% (CI 22–2
Haemophilus influenzae B 56 9% (CI 7–11
Other pathogen 183 28% (CI 25–3
Not identified 89 14% (CI 11–1
Total 655 100%
age (median, yr) 15 (IQR 1–51)
year of meningitis (median) 1999 (IQR 1991–200
time between audiometry and meningitis (median, d) n.a.
Otology & Neurotology, Vol. 39, No. 5, 201861 days after themeningitis, and the otoacoustic emissions
were present in some frequency bands for both ears. In
follow-up assessments (246 and 402 days aftermeningitis)
the latencies were almost conform age. From pure-tone
audiometry, taken at older ages, the hearing loss seemed
stable at 60 to 65 dB in both ears.
Onset
In the two patients from Cohort 3 who developed
hearing loss in the contralateral ear, results of the audio-
logical test at 4 and 8 weeks, respectively, after menin-
gitis were normal, and deterioration was detected at 3 and
8.5 months, respectively.
DISCUSSION
The incidence of documented hearing loss in the
studied population of 655 patients with bacterial men-
ingitis in a tertiary referral center was established at
28%. Only the patients with initially diagnosed hearing
loss after meningitis showed deterioration of hearing
over time. A review on this topic found a mean
incidence of 11%, with a large variation from 2 to
35% in the individual studies (6). A possible explana-
tion for the high incidence in our series is the low
percentage of available audiometry data. Cohort 2,
which was used to calculate the incidence of hearing
loss, might therefore be subject to selection bias. Those
without complaints of hearing loss—especially
adults—are less likely to be tested and were excluded
from the analysis when audiometric information was
lacking. As an additional reasoning, the incidence ofon, age, year of meningitis, and follow-up time
Cohort 2 252 Cohort 2—With HL 69
8%) 67 27% (CI 22–32%) 31 45% (CI 34–57%)
8%) 57 23% (CI 18–28%) 11 16% (CI 9–26%)
%) 30 12% (CI 8–16%) 8 12% (CI 8–16%)
1%) 63 25% (CI 20–31%) 11 16% (CI 9–26%)
6%) 35 14% (CI 10–19%) 8 12% (CI 8–16%)
252 100% 69 100%
0 (IQR 0–3) 1 (IQR 0–15)
8) 2005 (IQR 1993–2010) 2006 (IQR 1993–2011)
43 (IQR 19–105) 24 (IQR 11–101)
FIG. 2. Course of hearing capacity after meningitis.
REPEATED AUDIOMETRY AFTER BACTERIAL MENINGITIS e305hearing loss in our adult population was higher than
that in the younger population. Given that the oldest
person in our cohort was aged 69 years, we think it is
unlikely that the high incidence of hearing loss in the
adult population can be explained by an age-depen-
dent, clinically not relevant hearing loss (15).
Patient selection could be a second possible explanation
for the high incidence of post meningitis hearing loss we
found. In a previous study it was suggested that hearing
loss after meningitis is related to the severity of meningitis
(8). Although we lacked information on the disease sever-
ity for a number of patients, the fact that the Erasmus
Medical Centre is a tertiary referral center with potential
selection of higher severity meningitis patients may have
resulted in an overestimation of the hearing loss risk.In our series, changes in hearing loss were observed
between 4 weeks and 8 months after meningitis. A
systematic review has found earlier onset of hearing loss,
which nevertheless often improved in the early phase of
the meningitis (9,10).
An important finding is that normal hearing at first
audiometric assessment remained stable over time in all
patients. Hence, patients with normal hearing immedi-
ately after the infection run little risk of developing
hearing loss. This observation is confirmed by our sys-
tematic review on this subject, in which only one patients
of deterioration of normal hearing is described: a young
baby developed a bilateral severe hearing loss. However,
no further information was available for this patients
(6,12). We can conclude that repeated audiometry isOtology & Neurotology, Vol. 39, No. 5, 2018
e306 M. B. A. RODENBURG-VLOT ET AL.unnecessary for this group. However hearing loss occur-
ring immediately after the infection should be regularly
monitored with hearing tests for both ears.
A remarkable finding is that two patients with unilateral
hearing loss developed hearing loss in the contralateral,
initially normal hearing, ear. The question could be raised,
therefore, whether this supports the proposition that initial
normal hearing candeteriorate over timeaftermeningitis, or
whether this is a different situation with another origin?
Patients of this kindhavebeendescribed in the literature, but
these were not caused by bacterial meningitis (16). We did
not find an explanation for this in ourdata or in the literature,
apart from some suggestions that endolymphatic hydrops
can lead to fluctuating hearing loss after meningitis (17) or
that it could be explained by autoimmunity (18).
A major limitation of this study is that audiometric data
was available for only 30% of the patients in our hospital.
Conversion to a noncompliance ratio is not possible, as a
number of patients were transferred to another hospital
before audiometry was done. However, for the majority of
patients the reason for the absence of audiometric data was
unclear, especially for the adult patients, which may point
to flawed protocol adherence. For thatmatter, adherence to
the audiometry follow-up protocol in our hospital seems to
be lower than reported elsewhere (19). Also, the number of
patients with repeated audiometry was relatively small:
110 out of 252 patients.
Furthermore, clinical characteristics of patients were
not taken into account. Therefore, we cannot confirm
hearing loss due to known associations with clinical
characteristics, such as ataxia, S. pneumoniae as causa-
tive pathogen, low cerebrospinal fluid glucose level,
absence of petechial, or longer duration of symptoms
before admission (20).
CONCLUSION
Hearing loss after meningitis is difficult to study:
although we started with a large pool of included menin-
gitis patients, we ended up with only a small portion for
which enough audiometric data were available. In future
research this could be overcome by conducting a prospec-
tive study, and ensuring better adherence to the audiologi-
cal follow-up protocol.We hope that our findingswill help
create more awareness of the importance of audiological
testing after meningitis. These should be started as soon as
the acute phase is over. This is most important for (young)
children,who are less likely to complain about hearing loss
and who more often suffer from a profound hearing loss.
Repeated audiometry is only needed for those who show
hearing loss at the first test.Otology & Neurotology, Vol. 39, No. 5, 2018REFERENCES
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